Xelari Inc

Xelari builds a new operating layer for molecular design. Our hybrid agentic AI architecture replaces long stochastic discovery with deterministic computation. Instead of months of evolutionary screening, each target becomes a defined computational task with predictable hours scale turnaround and reproducible results. This process unlocks a structural shift in biotech productivity: • design becomes programmable, not stochastic • workflows scale from single targets to full proteome coverage • thousands of targets can be processed in parallel • outputs remain consistent across runs The result is a scalable infrastructure for life science teams who need fast, reliable, and repeatable molecular tools for diagnostics, proteomics, and therapeutic research. Xelari moves biology from artisanal trial and error to an operational, computationally driven pipeline.